Incidence, clinical characteristics, and outcomes of nosocomial Enterococcus spp. bloodstream infections in a tertiary-care hospital in Beijing, China: a four-year retrospective study
- PMID: 28680588
- PMCID: PMC5496248
- DOI: 10.1186/s13756-017-0231-y
Incidence, clinical characteristics, and outcomes of nosocomial Enterococcus spp. bloodstream infections in a tertiary-care hospital in Beijing, China: a four-year retrospective study
Abstract
Background: Enterococcus spp. are the common cause of nosocomial bloodstream infections (BSIs) with high morbidity and mortality. The purpose of this study was to characterize the incidence, clinical and microbiological features, and mortality of nosocomial enterococcal BSIs at a large Chinese tertiary-care hospital in Beijing, China.
Methods: A retrospective cohort study on adult patients with nosocomial BSIs due to Enterococcus spp. was performed between January 1, 2012, and December 31, 2015 at the Chinese People's Liberation Army General Hospital. Patients' data were gathered by reviewing electronic medical records.
Results: A total of 233 episodes of BSI due to Enterococcus spp. occurred among 224 patients during these 4 years. The overall incidence was 3.9 episodes per 10,000 admissions. Enterococcus faecium (E. faecium) was the major pathogen (74%, 95% CI 68-80%), followed by Enterococcus faecalis (E. faecalis) (20%, 95% CI 15-25%). E. faecium showed higher antimicrobial resistance than E. faecalis. The 30-day mortality of nosocomial enterococcal BSI was 24% (95% CI 18-29%). Predictors for mortality included the Acute Physiology and Chronic Health Evaluation II (APACHE II) score, Charlson comorbidity index (CCI), impaired renal function, prior use of immunosuppressive agents, and appropriate empirical antimicrobial treatment.
Conclusions: This study emphasizes that Enterococcus spp. were major pathogens for nosocomial BSIs and associated with high mortality. Appropriate empirical antimicrobial treatment can improve outcomes. Vancomycin is the best choice for patients with E. faecium BSIs. Penicillins, aminoglycosides, fluoroquinolones, and vancomycin can be considered for patients with E. faecalis BSIs.
Keywords: Bacteraemia; Enterococcus; Epidemiology; Mortality; Nosocomial bloodstream infection.
Conflict of interest statement
Ethics approval and consent to participate
This study was approved by the local institutional review board. For this type of study formal consent is not required.
Consent for publication
Not applicable.
Competing interests
None of authors declare conflicts of interest relevant to this article.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
References
-
- Pfaller MA, Jones RN, Doern GV, Sader HS, Kugler KC, Beach ML. Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY antimicrobial surveillance program. SENTRY participants group. Diagn Microbiol Infect Dis. 1999;33(4):283–297. doi: 10.1016/S0732-8893(98)00149-7. - DOI - PubMed
-
- Huang YC, Xie Y, Chen ZX, Liu B, Fei Y, Du Y, Shan B, Kang M. Bloodstream infections in southwestern China: 2012 Whire union report on bacterial susceptibility to antibiotics. Sichuan da xue xue bao Yi xue ban. 2015;46(1):75–81. - PubMed
-
- Guanghui ZD LI, Fu WANG, Zhidong HU, Quan LI, Ziyong SUN. The distribution and antibiotic resistance of clinical isolates from blood culture in 2012 CHINET surveillance program in China. Chin J Chemother. 2014;14(6):474–481.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
